- Sources fused
- 1
- Resolved records
- 2
An absent edge means not yet observed — never does not exist.
JOHN MILLER
JOHN MILLER — US company (icij:icijol-56041722). 2 sanctions/PEP signals, 4 holdings. Cited to 1 registry.
One real-world entity, resolved into a single cited record across 2 independent sources.
Investigative lead by resolved identity, not a legal determination.
Also appears in
opensanctions_pep · opensanctions_debarmentThe same real-world entity, resolved across sources.
Ownership & control
Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.
None in current sources.
- JOHN MILLER
- SHIRE PHARMACEUTICAL INVESTMENT HOLDINGS LIMITED· director of
- SHIRE PHARMACEUTICAL INVESTMENT LIMITED· director of
Nothing further is withheld here. The ownership and control links above are everything we have resolved for JOHN MILLER — there is no deeper chain behind a paywall. Absence means “not observed in our current sources” — it is not a finding of none.
Coverage of JOHN MILLER is still thin in the current sources. Watch it and we'll flag the moment new ownership, filings or risk signals land.
Explore US coverage4 items you can read right now — no account, no payment.
- Identity, address & registry profile
- Sanctions & watchlist detail
- Direct connections (1 hop)
- Community notes
Nothing further on JOHN MILLER is behind a paywall — everything we hold on this subject is already on this page.
People & control
2 parties · 0 currentEvery officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.
- SHIRE PHARMACEUTICAL INVESTMENT HOLDINGS LIMITEDAlso holds roles at 6 other companies
- MICHAEL C. SCHMIDTsecretary of
- MICHAEL E. CHAPMANdirector of
- MICHAEL E. CHAPMANlegal representative of
- SHIRE PHARMACEUTICAL INVESTMENT LIMITEDAlso holds roles at 6 other companies
- MICHAEL C. SCHMIDTsecretary of
- SHIRE PHARMACEUTICALS GROUPshareholder of
- MICHAEL E. CHAPMANdirector of
2 parties · 0 current. Ceased and resigned records are retained as history.
Sanctions & watchlists
Evidence-groundedSanctions signals are evidence-grounded investigative leads from public lists (OFAC / EU / UN / UK OFSI) — not a legal determination.
Common questions
- Who owns JOHN MILLER?
- What is JOHN MILLER's risk level?
- Where does JOHN MILLER appear across sources?
Community intel
Crowd leads · unverifiedIs this your company?
Open the inbox for this record, read what has been put to it, and answer on the record. You will be asked to show that you can act for JOHN MILLER — nothing is disclosed before that.